Tissue inhibitor of metalloproteinase‐1 levels in plasma from tumour arteries and veins of patients with rectal cancer

References

• Curran S., Murray G. I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36: 1621–30
   PubMed Web of Science ®Google Scholar
• Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161–74
   PubMed Web of Science ®Google Scholar
• Folgueras A. R., Pendas A. M., Sanchez L. M., Lopez‐Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004; 48: 411–24
   PubMed Web of Science ®Google Scholar
• Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477: 267–83
   PubMed Web of Science ®Google Scholar
• Wurtz S. O., Christensen I. J., Schrohl A. S., et al. Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases‐1 in the prognostic evaluation of primary breast cancer patients. Mol Cell Proteomics 2005; 4: 483–91
   PubMed Web of Science ®Google Scholar
• Holten‐Andersen M. N., Murphy G., Nielsen H. J., et al. Quantitation of TIMP‐1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer 1999; 80: 495–503
   PubMed Web of Science ®Google Scholar
• Lambert E., Dasse E., Haye B., Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004; 49: 187–98
   PubMed Web of Science ®Google Scholar
• Holten‐Andersen M. N., Christensen I. J., Nielsen H. J., et al. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Cancer Res 2002; 8: 156–64
   PubMed Web of Science ®Google Scholar
• Holten‐Andersen M., Christensen I. J., Nilbert M., et al. Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study. Eur J Cancer 2004; 40: 64–72
   PubMed Web of Science ®Google Scholar
• Waas E. T., Hendriks T., Lomme R. M., Wobbes T. Plasma levels of matrix metalloproteinase‐2 and tissue inhibitor of metalloproteinase‐1 correlate with disease stage and survival in colorectal cancer patients. Dis Colon Rectum 2005; 48: 700–10
   PubMed Web of Science ®Google Scholar
• Holten‐Andersen M. N., Stephens R. W., Nielsen H. J., et al. High preoperative plasma tissue inhibitor of metalloproteinase‐1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res 2000; 6: 4292–9
   PubMed Web of Science ®Google Scholar
• Liu X. W., Bernardo M. M., Fridman R., Kim H. R. Tissue inhibitor of metalloproteinase‐1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3‐kinase and MAPK signaling pathway. J Biol Chem 2003; 278: 40364–72
   PubMed Web of Science ®Google Scholar
• Murphy F. R., Issa R., Zhou X., et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase‐1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 2002; 277: 11069–76
   PubMed Web of Science ®Google Scholar
• Hayakawa T., Yamashita K., Tanzawa K., et al. Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992; 298: 29–32
   PubMed Web of Science ®Google Scholar
• Cornelius L. A., Nehring L. C., Harding E., et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 1998; 161: 6845–52
   PubMed Web of Science ®Google Scholar
• Fernandez H. A., Kallenbach K., Seghezzi G., et al. Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases‐1. J Surg Res 1999; 82: 156–62
   PubMed Web of Science ®Google Scholar
• Price B., Dennison C., Tschesche H., Elliott E. Neutrophil tissue inhibitor of matrix metalloproteinases‐1 occurs in novel vesicles that do not fuse with the phagosome. J Biol Chem 2000; 275: 28308–15
   PubMed Web of Science ®Google Scholar
• Cooper T. W., Eisen A. Z., Stricklin G. P., Welgus H. G. Platelet‐derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci USA 1985; 82: 2779–83
   PubMed Web of Science ®Google Scholar
• Holten‐Andersen M. N., Hansen U., Brunner N., et al. Localization of tissue inhibitor of metalloproteinases 1 (TIMP‐1) in human colorectal adenoma and adenocarcinoma. Int J Cancer 2005; 113: 198–206
   PubMed Web of Science ®Google Scholar
• Hembry R. M., Murphy G., Reynolds J. J. Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci 1985; 73: 105–19
   PubMed Web of Science ®Google Scholar
• Murphy G., Houbrechts A., Cockett M. I., et al. The N‐terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 1991; 30: 8097–102
   PubMed Web of Science ®Google Scholar
• Cooksley S., Hipkiss J. B., Tickle S. P., et al. Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme‐inhibitor complexes. Matrix 1990; 10: 285–91
   PubMedGoogle Scholar
• Murate T., Yamashita K., Isogai C., et al. The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet‐ and megakaryocyte‐derived TIMPs in bone marrow fibrosis. Br J Haematol 1997; 99: 181–9
   PubMed Web of Science ®Google Scholar
• Hammer J. H., Basse L., Svendsen M. N., et al. Impact of elective resection on plasma TIMP‐1 levels in patients with colon cancer. Colorectal Dis 2006; 8: 168–72
   PubMed Web of Science ®Google Scholar
• Coussens L. M., Werb Z. Inflammation and cancer. Nature 2002; 420: 860–7
   PubMed Web of Science ®Google Scholar
• Nielsen H. J., Hansen U., Christensen I. J., et al. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999; 189: 487–95
   PubMed Web of Science ®Google Scholar